Business Information
The group's principle activities include developing, manufacturing and marketing next-generation immunodiagnostic tests for drugs of abuse testing, therapeutic drug monitoring, calibration and linearity verification, and controls. The group's products include CEDIA(R), DRI(R), MAS(R), LabLink(R) xL, and CASCO(R). The group operates from United States.
|
|
Name |
Title
|
Email
|
| Darren Locklin | Regional Sales Mgr. - CT, ME, MA | N/A | | Donna Griswold | Regional Sales Mgr. - CT, ME, MA | N/A | | George Mills | Regional Sales Mgr. - AK, CA, ID, MT, NV | N/A | | John Demuth | Regional Sales Mgr. - DC, GA, MD | N/A | | John Hennell | Regional Sales Mgr. - IL, IA, MI, MN | N/A |
|
| Sales Range | 250 to 1000 Million | | Employee Range | 2001 to 10000 |
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
